PNL8 ASSESSING THE COST-EFFECTIVENESS OF IMMUNOMODULATORYTHERAPIES FOR RELAPSING-REMITTING MULTIPLE SCLEROSIS BASED ON LONG-TERM DATA
CF Bell, JB Graham, SR Earnshaw, M Oleen-Burkey, J Castelli-Haley, KP JohnsonVolume:
9
Year:
2006
Language:
english
DOI:
10.1016/s1098-3015(10)64557-3
File:
PDF, 63 KB
english, 2006